Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8459 Cr | ₹1339 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 21% | 26.49% |
| Expense Ratio | 1.82 | 2.14 |
| Manager | Sailesh Raj Bhan | Meeta Shetty |
| ISIN Code | INF204K01968 | INF277K016A9 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -2.24% | -2.42% |
| 6 Month | -0.03% | 1.38% |
| 1 Year | -1.23% | -2.49% |
| 3 Year | 21.3% | 21.65% |
| 5 Year | 15.18% | 14.94% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -0.82% | -1.22% |
| 1 Year | 4.97% | 4.63% |
| 3 Year | 16.4% | 17.22% |
| 5 Year | 16.13% | 16.69% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 16.62% | 8.33% |
| 3 Year | 20.93% | 18.87% |
| 5 Year | 20.36% | 15.74% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 16.04% |
| Sharp | 0.98% | 0.91% |
| Beta | 0.87% | 0.98% |
| Alpha | 1.45% | -1.01% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Meeta Shetty |
| Total AUM | ₹96086 Cr | ₹17847 Cr |
| Funds Managed | 5 | 5 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.34 | 6.27 |
| Mid Cap | 35.32 | 39.01 |
| Small Cap | 30.74 | 35.21 |
| Large Cap | 32.6 | 19.5 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 0.55 | 5.02 |
| Healthcare | 99.45 | 90.83 |
| Basic Materials | - | 4.14 |
Top Comparisons
ICICI Prudential Global Stable Equity Fund (FOF) - Growth
3Y Returns11.65%
Axis Global Innovation Fund of Fund - Regular Plan - Growth
3Y Returns22.41%
HDFC MNC Fund - Regular (G)
3Y Returns0%
UTI - MNC Fund - Regular Plan - Growth Option
3Y Returns13.04%
Bandhan Overnight Fund Regular - Growth
3Y Returns6.31%
UTI - Overnight Fund - Regular Plan - Growth Option
3Y Returns6.37%
Franklin India Technology Fund-Growth
3Y Returns23.77%
SBI Technology Opportunities Fund Regular Growth
3Y Returns17.96%